GUIDED THERAPEUTICS INC Contracts & Agreements

Form of Warrant dated December 18, 2024 (Filed With SEC on December 23, 2024)

Form of Securities Purchase Agreement dated December 18, 2024 (Filed With SEC on December 23, 2024)

Form of Promissory Note issued to Directors (Filed With SEC on November 14, 2024)

Promissory Note, dated July 23, 2024, in the amount of $50,000 (Filed With SEC on November 14, 2024)

Common Stock Purchase Warrant, dated August 1, 2024 (Filed With SEC on November 14, 2024)

Form of Common Stock Purchase Warrants issued to Directors (Filed With SEC on November 14, 2024)

Form of Warrant (Filed With SEC on September 27, 2024)

Form of Securities Purchase Agreement (Filed With SEC on September 27, 2024)

$100,000 Promissory Note Dated June 28, 2024 and Related Common Stock Purchase Warrant (Filed With SEC on August 14, 2024)

Exchange Agreement dated April 15, 2024 (Filed With SEC on August 14, 2024)

Securities Purchase Agreement with 1800 Diagonal Lending (Filed With SEC on August 14, 2024)

$100,050 Promissory Note Dated June 11, 2024 with 1800 Diagonal Lending (Filed With SEC on August 14, 2024)

$50,000 Promissory Note Dated July 23, 2024 and related Common Stock Purchase Warrant Dated August 1, 2024 (Filed With SEC on August 14, 2024)

Form of Promissory Notes Issued to Directors and Form of Related Common Stock Purchase Warrants (Filed With SEC on August 14, 2024)

Securities Purchase Agreement with 1800 Diagonal Lending, dated July 22, 2024 (Filed With SEC on August 14, 2024)

$62,100 Promissory Note Dated July 22, 2024 with 1800 Diagonal Lending (Filed With SEC on August 14, 2024)

Form of Common Stock Purchase Warrant Issued to Richard Blumberg (Filed With SEC on May 15, 2023)

Form of 2023 Warrant Exchange Agreements (Filed With SEC on May 15, 2023)

Form of Amended Promissory Note to Gene Cartwright (Filed With SEC on May 15, 2023)

Form of Amended Promissory Note to Mark Faupel (Filed With SEC on May 15, 2023)

Amendment #1 to Exchange Agreement between the Company and Auctus Fund, LLC (Filed With SEC on November 14, 2022)

Form of Warrant (Filed With SEC on September 15, 2022)

Form Securities Purchase Agreement (Filed With SEC on September 15, 2022)

Exchange Agreement between the Company and Auctus Fund, LLC (Filed With SEC on September 15, 2022)

Form of Warrants issued to Auctus Fund, LLC (Filed With SEC on September 15, 2022)

Form of Public Warrant (Filed With SEC on July 13, 2022)

Form of Underwriting Agreement (Filed With SEC on June 30, 2022)

Form of Warrant Agency Agreement (Filed With SEC on June 30, 2022)

EXCHANGE AGREEMENT (Filed With SEC on June 30, 2022)

Form of Common Stock Purchase Warrant (Aspen Capital) dated May 31, 2021 (Filed With SEC on March 30, 2022)

Form of Common Stock Purchase Warrant (Iron Stone Capital) dated August 10, 2021 (Filed With SEC on March 30, 2022)

Form of Common Stock Purchase Warrant dated November 4, 2021 (Filed With SEC on March 30, 2022)

Agreement dated September 30, 2021, by and between Guided Therapeutics, Inc. and Richard P. Blumberg (Filed With SEC on March 30, 2022)

Exchange Agreement, dated as of December 10, 2021, by and between Guided Therapeutics, Inc. and John Imhoff, M.D (Filed With SEC on March 30, 2022)

Exchange Agreement, dated as of December 20, 2021, by and between Guided Therapeutics, Inc. and John Gould (Filed With SEC on March 30, 2022)

Exchange Agreement, dated as of December 13, 2021, by and between Guided Therapeutics, Inc. and Frederick Grimm (Filed With SEC on March 30, 2022)

Exchange Agreement, dated as of December 16, 2021, by and between Guided Therapeutics, Inc. and Richard P. Blumberg, Esq (Filed With SEC on March 30, 2022)

Exchange Agreement, dated as of December 16, 2021, by and between Guided Therapeutics, Inc. and K2 Medical, LLC (Filed With SEC on March 30, 2022)

Exchange Agreement, dated as of December 20, 2021, by and between Guided Therapeutics, Inc. and Gene S. Cartwright (Filed With SEC on March 30, 2022)

Exchange Agreement, dated as of December 20, 2021, by and between Guided Therapeutics, Inc. and Mark L. Faupel (Filed With SEC on March 30, 2022)

Exchange Agreement, dated as of December 21, 2021, by and between Guided Therapeutics, Inc. and Flynn D. Case Living Trust (Filed With SEC on March 30, 2022)

Exchange Agreement, dated as of December 21, 2021, by and between Guided Therapeutics, Inc. and GPB Debt Holdings II LLC (Filed With SEC on March 30, 2022)

Exchange Agreement, dated as of December 21, 2021, by and between Guided Therapeutics, Inc. and Michael C. James (Filed With SEC on March 30, 2022)

Exchange Agreement, dated as of December 30, 2021, by and between Guided Therapeutics, Inc. and Bryan Mamula (Filed With SEC on March 30, 2022)

Exchange Agreement, dated as of December 30, 2021, by and between Guided Therapeutics, Inc. and Dolores Maloof (Filed With SEC on March 30, 2022)

Promissory Note, dated December 31, 2021, by and between Guided Therapeutics, Inc. and William Wells (Filed With SEC on March 30, 2022)

EXCHANGE AGREEMENT (Filed With SEC on March 30, 2022)

Exchange Agreement dated February 1, 2022, by and between Guided Therapeutics, Inc. and Auctus Fund LLC (Filed With SEC on March 30, 2022)

Form of Underwriting Agreement (Filed With SEC on February 17, 2022)

Form of Pre-Funded Warrant (Filed With SEC on February 17, 2022)

Form of Public Warrant (Filed With SEC on February 17, 2022)

Exchange Agreement, dated as of June 23, 2020, by and between Guided Therapeutics, Inc. and James Clavijo (Filed With SEC on February 17, 2022)

Amendment to the Agreement by and between Guided Therapeutics Inc. and Shandong Yaohua Medical Instrument Corporation, dated August 12, 2021 (Filed With SEC on September 7, 2021)

Form of Acknowledgement (Filed With SEC on June 10, 2021)

Convertible Promissory Note with Auctus, dated March 31, 2020 (Filed With SEC on April 7, 2021)

Form of Warrant (Auctus Note), dated March 31, 2020 (Filed With SEC on April 7, 2021)

Form of Warrant (Series D Preferred Stock) (Filed With SEC on April 7, 2021)

Form of Warrant (Ironstone Capital), dated April 23, 2020 (Filed With SEC on April 7, 2021)

Form of Warrant (Auctus Note), dated May 22, 2020 (Filed With SEC on April 7, 2021)

Form of Warrant (Credential Qtrade Securities Inc. ITF Reve Royalty Income Growth, dated as of June 23, 2020 (Filed With SEC on April 7, 2021)

Form of Warrant (James Clavijo), dated June 23, 2020 (Filed With SEC on April 7, 2021)

Form of Warrant (Manju Venugopal), dated August 10, 2020 (Filed With SEC on April 7, 2021)

Note Payable Agreement with Gene Cartwright, dated February 19, 2021 (Filed With SEC on April 7, 2021)

Note Payable Agreement with Mark Faupel, dated February 19, 2021 (Filed With SEC on April 7, 2021)

Form of Warrant (Aspen Capital), dated June 23, 2020 (Filed With SEC on April 7, 2021)

Finders Fee Agreement with JH Darbie, dated as of May 19, 2020 (Filed With SEC on April 7, 2021)

Debt for Equity Exchange Agreement with Auctus, dated as of May 22, 2020 (Filed With SEC on April 7, 2021)

Securities Purchase Agreement with Auctus, dated as of May 27, 2020 (Filed With SEC on April 7, 2021)

Finders Fee Agreement with FCMI, dated as of June 11, 2020 (Filed With SEC on April 7, 2021)

Exchange Agreement with William Wells, dated as of July 9, 2020 (Filed With SEC on April 7, 2021)

Securities Purchase Agreement with PowerUp, dated as of December 24, 2020 (Filed With SEC on April 7, 2021)

Securities Purchase Agreement with PowerUp, dated as of February 10, 2021 (Filed With SEC on April 7, 2021)

Consulting Agreement with Richard Blumberg, dated as of March 11, 2021 (Filed With SEC on April 7, 2021)

Exchange Agreement with Richard Fowler, dated as of March 22, 2021 (Filed With SEC on April 7, 2021)

Securities Purchase Agreement (Series E), dated June 30, 2020 (Filed With SEC on April 7, 2021)

Securities Purchase Agreement (Series F), dated March 31, 2020 (Filed With SEC on April 7, 2021)

Senior Secured Convertible Note, dated December 17, 2019, by and between Guided Therapeutics, Inc. and Auctus Fund, LLC (Filed With SEC on April 20, 2020)

Common Stock Warrant, dated December 17, 2019, by and between Guided Therapeutics, Inc. and Auctus Fund, LLC (Filed With SEC on April 20, 2020)

Form of Common Stock Purchase Warrant (Filed With SEC on April 20, 2020)

Form of 12% debenture (Filed With SEC on April 20, 2020)

Form of Warrant (Exchange Agreements) (Filed With SEC on April 20, 2020)

Form of Common Stock Purchase Warrant (Filed With SEC on April 20, 2020)

Securities Purchase Agreement, dated as of February 12, 2018, by and between Guided Therapeutics, Inc. and Adar Bays, LLC (Filed With SEC on April 20, 2020)

Securities Purchase Agreement, dated as of February 22, 2018, by and between Guided Therapeutics, Inc. and Power Up (Filed With SEC on April 20, 2020)

Lease Modification, dated as of February 23, 2018, by and between Guided Therapeutics, Inc. and TREA Infill Industrial Atlanta, LLC (Filed With SEC on April 20, 2020)

Securities Purchase Agreement, dated as of March 12, 2018, by and between Guided Therapeutics, Inc. and Eagle Equities, LLC (Filed With SEC on April 20, 2020)

Securities Purchase Agreement, dated as of May 17, 2018, by and between Guided Therapeutics, Inc. and GHS Investments, Inc (Filed With SEC on April 20, 2020)

Securities Purchase Agreement, dated as of March 20, 2018, by and between Guided Therapeutics, Inc. and Auctus Fund, LLC (Filed With SEC on April 20, 2020)

Securities Purchase Agreement, dated as of April 30, 2018, by and between Guided Therapeutics, Inc. and Power Up (Filed With SEC on April 20, 2020)

Securities Purchase Agreement, dated as of June 7, 2018, by and between Guided Therapeutics, Inc. and Power Up (Filed With SEC on April 20, 2020)

Securities Purchase Agreement, dated as of June 22, 2018, by and between Guided Therapeutics, Inc. and GHS Investments, Inc (Filed With SEC on April 20, 2020)

Securities Purchase Agreement, dated as of July 3, 2018, by and between Guided Therapeutics, Inc. and Auctus Fund, LLC (Filed With SEC on April 20, 2020)

Promissory Note, dated as of August 22, 2018, by and between Guided Therapeutics, Inc. and Mr. Case (Filed With SEC on April 20, 2020)

Promissory Note, dated as of September 19, 2018, by and between Guided Therapeutics, Inc. and Mr. Gould (Filed With SEC on April 20, 2020)

Exchange Agreement, dated as of September 30, 2018, by and between Guided Therapeutics, Inc. and Dr. Faupel (Filed With SEC on April 20, 2020)

Exchange Agreement, dated as of September 30, 2018, by and between Guided Therapeutics, Inc. and Dr. Cartwright (Filed With SEC on April 20, 2020)

Equity Financing Agreement, dated as of March 1, 2018, by and between Guided Therapeutics, Inc. and GHS Investments, Inc (Filed With SEC on April 20, 2020)

Purchase and Sale Agreement, dated as of February 14, 2019, by and between Guided Therapeutics, Inc. and Everest Business Funding (Filed With SEC on April 20, 2020)

Promissory Note, dated as of February 15, 2019, by and between Guided Therapeutics, Inc. and Mr. Gould (Filed With SEC on April 20, 2020)

Securities Purchase Agreement, dated as of March 29, 2019, by and between Guided Therapeutics, Inc. and Auctus Fund, LLC (Filed With SEC on April 20, 2020)

Securities Purchase Agreement, dated as of May 15, 2019, by and between Guided Therapeutics, Inc. and Eagle Equities, LLC (Filed With SEC on April 20, 2020)

Securities Purchase Agreement, dated as of May 15, 2019, by and between Guided Therapeutics, Inc. and Adar Bays, LLC (Filed With SEC on April 20, 2020)

Loan Agreement, dated as of July 1, 2019, by and between Guided Therapeutics, Inc. and Accilent Capital Management Inc. / Rev Royalty Trust Income and Growth Trust (Filed With SEC on April 20, 2020)

License Agreement Modification, dated as of July 24, 2019, by and between Guided Therapeutics, Inc. and Shandong Medical Instrument Corporation (Filed With SEC on April 20, 2020)

Addendum to the Exchange Agreement, dated as of September 30, 2018, by and between Guided Therapeutics, Inc. and Dr. Faupel (Filed With SEC on April 20, 2020)

Addendum to the Exchange Agreement, dated as of September 30, 2018, by and between Guided Therapeutics, Inc. and Dr. Cartwright (Filed With SEC on April 20, 2020)

Exchange Agreement, dated as of December 5, 2019, by and between Guided Therapeutics, Inc. and Aquarius (Filed With SEC on April 20, 2020)

Securities Purchase Agreement, dated as of December 17, 2019, by and between Guided Therapeutics, Inc. and Auctus Fund, LLC (Filed With SEC on April 20, 2020)

Security Agreement, dated December 17, 2019, by and between Guided Therapeutics, Inc. and Auctus Fund, LLC (Filed With SEC on April 20, 2020)

Registration Rights Agreement, dated December 17, 2019, by and between Guided Therapeutics, Inc. and Auctus Fund, LLC (Filed With SEC on April 20, 2020)

Form of Securities Purchase Agreement between the Guided Therapeutics, Inc. and investors set forth therein (Filed With SEC on April 20, 2020)

Form of Security Agreement between the Guided Therapeutics, Inc. and investors set forth therein (Filed With SEC on April 20, 2020)

Registration Rights Agreement (Series D), dated December 30, 2019 (Filed With SEC on April 20, 2020)

Form of Joinder Agreement (Series D), dated December 30, 2019 (Filed With SEC on April 20, 2020)

Form of Exchange Agreement, dated as of December 30, 2019, by and between Guided Therapeutics, Inc. and Investors (Filed With SEC on April 20, 2020)

Exchange Agreement, dated as of December 30, 2019, by and between Guided Therapeutics, Inc. and K2 (Filed With SEC on April 20, 2020)

Exchange Agreement, dated as of December 30, 2019, by and between Guided Therapeutics, Inc. and Mr. Blumberg (Filed With SEC on April 20, 2020)

Exchange Agreement, dated as of January 6, 2020, by and between Guided Therapeutics, Inc. and Jones Day Law Firm (Filed With SEC on April 20, 2020)

Exchange Agreement, dated as of December 30, 2019, by and between Guided Therapeutics, Inc. and Dr. Imhoff (Filed With SEC on April 20, 2020)

Finders Fee Agreement, dated as of January 6, 2020, by and between Guided Therapeutics, Inc. and Iron Stone Capital (Filed With SEC on April 20, 2020)

Promissory Note, dated as of January 15, 2020, by and between Guided Therapeutics, Inc. and IRTH Communications, LLC (Filed With SEC on April 20, 2020)

Exchange Agreement, dated as of January 16, 2020, by and between Guided Therapeutics, Inc. and GPB Debt Holdings II, LLC (Filed With SEC on April 20, 2020)

Promotional Agreement, dated as of January 22, 2020, by and between Guided Therapeutics, Inc. and Blumberg & Bowles Consulting, LLC (Filed With SEC on April 20, 2020)

Securities Purchase Agreement, dated as of March 31, 2020, by and between Guided Therapeutics, Inc. and Auctus Fund, LLC (Filed With SEC on April 20, 2020)

Form of Exchange Agreement (Filed With SEC on September 6, 2018)

Equity Financing Agreement dated March 1, 2018 by and between the Company and GHS Investments LLC (Filed With SEC on June 14, 2018)

Form of Registration Rights Agreement dated March 8, 2018 by and between the Company and GHS Investments LLC (Filed With SEC on June 14, 2018)

CONVERTIBLE PROMISSORY NOTE (Filed With SEC on November 13, 2017)

SECURITIES PURCHASE AGREEMENT (Filed With SEC on November 13, 2017)

SECURITIES PURCHASE AGREEMENT (Filed With SEC on October 25, 2017)

CONVERTIBLE PROMISSORYNOTE (Filed With SEC on August 24, 2017)

SECURITIES PURCHASE AGREEMENT (Filed With SEC on August 24, 2017)

Forbearance Agreement, dated August 8, 2017, between the Company and GPB Debt Holdings II LLC (Filed With SEC on August 17, 2017)

UNITED STATES SECURITIES AND EXCHANGECOMMISSION Washington, D.C.20549 FORM 8-K CURRENTREPORT Pursuant toSection 13 or 15(d) of the Securities ExchangeAct of 1934 Date of... (Filed With SEC on August 14, 2017)

COMMON STOCK PURCHASE WARRANT Guided Therapeutics, Inc. (Filed With SEC on June 7, 2017)

SECURITIES PURCHASE AGREEMENT (Filed With SEC on June 7, 2017)

PLACEMENT AGENCY AGREEMENT June __, 2017 (Filed With SEC on June 7, 2017)

GUIDEDTHERAPEUTICS, INC. 8%CONVERTIBLE REDEEMABLE NOTE DUEMAY 17, 2018 (Filed With SEC on May 24, 2017)

GUIDEDTHERAPEUTICS, INC. 8%CONVERTIBLE REDEEMABLE NOTE DUEMAY 17, 2018 BACKEND NOTE (Filed With SEC on May 24, 2017)

GUIDEDTHERAPEUTICS, INC. 8%CONVERTIBLE REDEEMABLE NOTE DUEMAY 17, 2018 (Filed With SEC on May 24, 2017)

GUIDEDTHERAPEUTICS, INC. 8%CONVERTIBLE REDEEMABLE NOTE DUEMAY 17, 2018 BACKEND NOTE (Filed With SEC on May 24, 2017)

SECURITIESPURCHASE AGREEMENT (Filed With SEC on May 24, 2017)

ADARBAYS, LLC COLLATERALIZEDSECURED PROMISSORY NOTE (Filed With SEC on May 24, 2017)

SECURITIESPURCHASE AGREEMENT (Filed With SEC on May 24, 2017)

[remainderof page intentionally left blank] (Filed With SEC on March 30, 2017)

Agreement, dated January 22, 2017, between the Company and Shandong Yaohua Medical Instrument Corporation (Filed With SEC on March 24, 2017)

CONVERTIBLEPROMISSORY NOTE (Filed With SEC on February 17, 2017)

COMMONSTOCK PURCHASE WARRANT GUIDEDTHERAPEUTICS, INC. (Filed With SEC on February 17, 2017)

SECURITIESPURCHASE AGREEMENT (Filed With SEC on February 17, 2017)

Agreement, dated January 22, 2017, between the Company and Shandong Yaohua Medical Instrument Corporation (Filed With SEC on January 26, 2017)

Agreement, dated January 22, 2017, between the Company and Shenghuo Medical, LLC (Filed With SEC on January 26, 2017)

10% OID Convertible Promissory Note (Filed With SEC on December 30, 2016)

Securities Purchase Agreement, dated December 28, 2016, between the Company and RedDiamond (Filed With SEC on December 30, 2016)

FORM OF NOTE (Filed With SEC on December 7, 2016)

EXCHANGE AGREEMENT (Filed With SEC on December 7, 2016)

AMENDMENT TO CONSULTING AGREEMENT (Filed With SEC on December 7, 2016)

LOCKUPAND EXCHANGE AGREEMENT (Filed With SEC on November 4, 2016)

RoyaltyAgreement (Filed With SEC on September 9, 2016)

RoyaltyAgreement (Filed With SEC on September 8, 2016)

COMMON STOCK PURCHASE WARRANT Guided Therapeutics, Inc. (Filed With SEC on July 1, 2016)

GUIDEDTHERAPEUTICS, INC. WarrantTo Purchase Common Stock (Filed With SEC on June 14, 2016)

WARRANTEXCHANGE AGREEMENT (Filed With SEC on June 14, 2016)

LICENSEAGREEMENT (Filed With SEC on June 8, 2016)

[remainderof page intentionally blank ] (Filed With SEC on May 3, 2016)

ROLLOVERAND AMENDMENT AGREEMENT (Filed With SEC on May 3, 2016)

AMENDMENT#8 (Filed With SEC on March 7, 2016)

17%Senior SECURED Convertible NOTE (Filed With SEC on February 16, 2016)

AMENDMENT#6 (Filed With SEC on February 16, 2016)

AMENDMENTAGREEMENT (Filed With SEC on February 16, 2016)

SECURITIESPURCHASE AGREEMENT (Filed With SEC on February 16, 2016)

SECURITYAGREEMENT (Filed With SEC on February 16, 2016)

COMMONSTOCK PURCHASE WARRANT GUIDEDTHERAPEUTICS, INC. (Filed With SEC on February 16, 2016)

___________________ Consulting Agreement ___________________ (Filed With SEC on February 16, 2016)

AMENDMENTTO SECURITIESPURCHASE AGREEMENT (Filed With SEC on February 16, 2016)

InterimSecurities Purchase Agreement (Filed With SEC on September 3, 2015)

FORMOF JoinderAgreement (Filed With SEC on July 13, 2015)

GuidedTherapeutics, INC. Common Stock Purchase Warrant (Filed With SEC on June 30, 2015)

SENIORCONVERTIBLE NOTE (Filed With SEC on June 30, 2015)

FORMOF WARRANT (Filed With SEC on June 30, 2015)

[remainder of page intentionally blank ] (Filed With SEC on June 30, 2015)

amendmentto securities purchase agreement (Filed With SEC on June 30, 2015)

EXCHANGEAGREEMENT (Filed With SEC on June 30, 2015)

AMENDMENT#4 (Filed With SEC on June 30, 2015)

AMENDMENT#5 (Filed With SEC on June 30, 2015)

SECURITIESPURCHASE AGREEMENT (Filed With SEC on June 30, 2015)

REGISTRATIONRIGHTS AGREEMENT (Filed With SEC on June 30, 2015)

AMENDMENT#3 (Filed With SEC on June 5, 2015)

AMENDMENT#2 (Filed With SEC on May 7, 2015)

Amendment, dated March 10, 2015, by and between the Company and Tonaquint (Filed With SEC on March 19, 2015)

GuidedTherapeutics, INC. Common Stock Purchase Warrant (Filed With SEC on December 4, 2014)

GUIDEDTHERAPEUTICS, INC. Common Stock Purchase Warrant (Placement Agent Warrant) (Filed With SEC on December 4, 2014)

SECURITIESPURCHASE AGREEMENT (Filed With SEC on December 4, 2014)

GUIDED THERAPEUTICS, INC. Up to 16,785,415 Shares of Common Stock 16,785,415 Warrants to Purchase up to8,392,708 Shares of Common Stock Up to 8,392,708 Shares of Common... (Filed With SEC on December 4, 2014)

GuidedTherapeutics, INC. Common Stock Purchase Warrant (Filed With SEC on December 3, 2014)

SECURITIESPURCHASE AGREEMENT (Filed With SEC on December 3, 2014)

GUIDED THERAPEUTICS, INC. Up to 25,178,123 Shares of Common Stock 25,178,123 Warrants to Purchase up to8,392,708 Shares of Common Stock Up to 8,392,708 Shares of Common... (Filed With SEC on December 3, 2014)

Guided Therapeutics, INC. Common Stock Purchase Warrant (Filed With SEC on November 19, 2014)

SECURITIESPURCHASE AGREEMENT (Filed With SEC on November 19, 2014)

GuidedTherapeutics, INC. Common Stock Purchase Warrant (Placement Agent Warrant) (Filed With SEC on November 10, 2014)

STANDSTILLAGREEMENT (Filed With SEC on November 10, 2014)

GUIDED THERAPEUTICS, INC. Up to __________ Shares of Common Stock __________ Warrants to Purchase up to__________ Shares of Common Stock Up to __________ Shares of Common... (Filed With SEC on November 10, 2014)

GuidedTherapeutics, INC. Common Stock Purchase Warrant (Filed With SEC on September 15, 2014)

SECURITIESPURCHASE AGREEMENT (Filed With SEC on September 15, 2014)

GUIDED THERAPEUTICS, INC. Up to __________ Shares of Common Stock __________ Warrants to Purchase up to__________ Shares of Common Stock Up to __________ Shares of Common... (Filed With SEC on September 15, 2014)

Secured Promissory Note, dated September 10, 2014 (Filed With SEC on September 10, 2014)

Note Purchase Agreement, dated September 10, 2014, by and between the Company and Tonaquint (Filed With SEC on September 10, 2014)

Secutity Agreement, dated September 10, 2014, by and between the Company and Tonaquint (Filed With SEC on September 10, 2014)

Form of Warrant (Regulation S) (Filed With SEC on September 8, 2014)

Subscription Agreement of ITEM, dated August 29, 2014, and acceptd by the Company on September 2, 2014 (Filed With SEC on September 8, 2014)

Form of Registration Rights Agreement (Filed With SEC on September 8, 2014)

Form of Senior Convertible Note (Filed With SEC on April 24, 2014)

Securities Purchase Agreement, dated as of April 23, 2014, by and between the Company and Hanover Holdings I, LLC (Filed With SEC on April 24, 2014)

Registration Rights Agreement, dated as of April 23, 2014, by and between the Company and Hanover Holdings I, LLC (Filed With SEC on April 24, 2014)

guidedtherapeutics, INC. COMMON STOCK WARRANT __________shares of Common Stock (Filed With SEC on March 26, 2014)

EMPLOYMENT AGREEMENT (Filed With SEC on March 26, 2014)

EmploymentAgreement (Filed With SEC on March 26, 2014)

EMPLOYMENT AGREEMENT (Filed With SEC on March 26, 2014)

Securities Purchase Agreement, by and among Guided Therapeutics, Inc. and the Purchasers named therein, dated May 21, 2013 (Filed With SEC on May 23, 2013)

Form of Warrant (Tranche A) (Filed With SEC on May 23, 2013)

Form of Warrant (Tranche B) (Filed With SEC on May 23, 2013)

Registration Rights Agreement, by and among Guided Therapeutics, Inc. and the Purchasers named therein, dated May 21, 2013 (Filed With SEC on May 23, 2013)

Securities Purchase Agreement, by and among Guided Therapeutics, Inc. and the Purchasers named therein, dated May 21, 2013 (Filed With SEC on May 23, 2013)

Form of Warrant (Tranche A) (Filed With SEC on May 23, 2013)

Form of Warrant (Tranche B) (Filed With SEC on May 23, 2013)

Registration Rights Agreement, by and among Guided Therapeutics, Inc. and the Purchasers named therein, dated May 21, 2013 (Filed With SEC on May 23, 2013)

Assigned Task Agreement (Filed With SEC on June 26, 2012)

Agreement for Collaboration in the Development of Spectroscopic Technology (Filed With SEC on June 26, 2012)

FORMOF WARRANT (Filed With SEC on November 28, 2011)

PRIVATESALE OF COMMON STOCK AND STOCK WARRANT SUBSCRIPTION AGREEMENT (Filed With SEC on November 28, 2011)

Exhibit A to Agreement and Release FORM OF WARRANT (Filed With SEC on September 2, 2011)

AGREEMENTAND RELEASE (Filed With SEC on September 2, 2011)

REGISTRATIONRIGHTS AGREEMENT (Filed With SEC on September 2, 2011)

Assigned Task Agreement (Filed With SEC on April 1, 2011)

Agreement for Collaboration in the Development of Spectroscopic Technology (Filed With SEC on April 1, 2011)

Form of Warrant Agreement (Filed With SEC on September 14, 2010)

Form of Subscription Agreement (Filed With SEC on September 14, 2010)

FIRST AMENDMENT TO AMENDED AND RESTATED LOAN AGREEMENT (Filed With SEC on August 12, 2010)

Agreement for Collaboration in the Development of Spectroscopic Technology (Filed With SEC on August 12, 2010)

Assigned Task Agreement Between Konica Minolta Opto, Inc. (KMOT) and Guided Therapeutics, Inc. (GT) February 1, 2010 Agreement for the Development of Spectroscopy for Barrett's... (Filed With SEC on May 13, 2010)

Amended Promissory Note (Maloof), April 10, 2008 (Filed With SEC on October 1, 2008)

Note Purchase Agreement (with Form of Promissory Note & Warrant) (Filed With SEC on October 1, 2008)

Warrant (Maloof), April 10, 2008 (Filed With SEC on October 1, 2008)

Dr. Walter PavlicekConsulting and Severance Agreement May 9, 2007 (Filed With SEC on June 5, 2007)

Mr. William Arthur IIISeverance Agreement May 9, 2007 (Filed With SEC on June 5, 2007)

Promissory note and Security Agreement dated as of October 26, 2005, by and among SpectRx, Inc. and the noteholders (Filed With SEC on November 1, 2005)

Payment Settlement Agreement dated as of October 27, 2005, by and among SpectRx. and Respironics (Filed With SEC on November 1, 2005)

News Release dated November 1, 2005 (Filed With SEC on November 1, 2005)

Promissory note and Security Agreement dated as of October 20, 2005, by and among SpectRx, Inc. and the noteholder (Filed With SEC on October 26, 2005)

Promissory note and Security Agreement dated as of October 5, 2005, by and among SpectRx, Inc. and the noteholders (Filed With SEC on October 12, 2005)

Promissory note and Security Agreement dated as of September 6, 2005, by and among SpectRx, Inc. and the officers (Filed With SEC on September 12, 2005)

Warrant Agreement dated as of August 8, 2005, by and among SpectRx, Inc. and the Investors (Filed With SEC on August 12, 2005)

Form of G (Filed With SEC on August 12, 2005)

Form of Amended and Restated Warrant (Filed With SEC on August 12, 2005)

Form of Option Agreement under 1995 Stock Option Plan (Filed With SEC on November 15, 2004)

Lease between Germania Property Investors ***, L.P. and SpectRx, Inc (Filed With SEC on August 16, 2004)

Agreement and Plan of Merger (Filed With SEC on January 14, 2002)

Category

Industry

Companies

Contracts

GUIDED THERAPEUTICS INC Contracts & Agreements